Assessment of morbidity in Schistosoma haematobium infection: Current methods and future tools

Acta Tropica

Volumn 77, Issue 1, 2000, Pages 81-89

  Jyding Vennervald, B ^a   Kahama, A I ^b   Reimert, C M ^a  

^a DANISH BILHARZIASIS LABORATORY   (Denmark)

^b Apt #6 75670 ^*  (United States)

Author keywords

Africa; Schistosoma haematobium; Worms

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; PARASITE ANTIGEN;

HEALTH SERVICES; METHODOLOGY; MONITORING; SCHISTOSOMIASIS;

ANTIGEN DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATURIA; HUMAN; MORBIDITY; NONHUMAN; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; URINALYSIS;

AFRICA; ANIMAL; ANTIGENS, HELMINTH; BIOLOGICAL MARKERS; BLADDER; BLOOD PROTEINS; COMPARATIVE STUDY; HUMAN; MORBIDITY; PARASITE EGG COUNT; PARASITOLOGY; PREVALENCE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; URINE;

EID: 0034706892     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(00)00116-9     Document Type: Article

References (58)

1. Amanor J.D., Bosompem K.M., Arishima T., Assoku R.K.G., Kojima S. Characterization of monoclonal antibodies reactive with Schistosoma haematobium-soluble egg and infected human urinary antigens. Hybridoma. 15:1996;219-224.
2. Bélec L., Meillet D., Lévy M., Georges A., Trévi-Bénissan C., Pillot J. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin. Diagn. Lab. Immunol. 2:1995;15-19.
3. Bosompem K.M., Arishima T., Yamashita T., Ayi I., Anyan W.K., Kojima S. Extraction of Schistosoma haematobium antigens from infected human urine and generation of potential diagnostic monoclonal antibodies to urinary antigens. Acta Trop. 62:1996;91-103.
4. Bosompem K.M., Ayi I., Anyan W.K., Nkrumah F.K., Kojima S. Limited field evaluation of a rapid monoclonal antibody-based dipstick assay for urinary schistosomiasis. Hybridoma. 15:1996;443-447.
5. Bosompem K.M., Ayi I., Anyan W.K., Arishima T., Nkrumah F.K., Kojima S. A monoclonal antibody-based dipstick assay for diagnosis of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 91:1997;554-556.
6. Burki A., Tanner M., Burnier E., Schweizer W., Meudt R., Degrémont A. Comparison of ultrasonography, intravenous pyelography and cystoscopy in detection of urinary tract lesions due to Schistosoma haematobium. Acta Trop. 43:1986;139-151.
7. Butterworth A.E., Sturrock R.F., Houba V., Mahmoud A.A., Sher A., Rees P.H. Eosinophils as mediators of antibody dependent damage to schistosomula. Nature. 256:1975;727-729.
8. Chen M.G., Mott K.E. Progress in assessment of morbidity due to Schistosoma haematobium infection: a review of recent literature. Trop. Dis. Bull. 86:1989;R1-R36.
9. Deelder A.M., Qian Z.L., Kremsner P.G., Acosta L., Rabello A.L.T., Enyong P., Simarro P.P., Van Etten E.C.M., Krijger F.W., Rotmans J.P., Fillié Y.E., De Jonge N., Agnew A.M., Van Lieshout L. Quantitative diagnosis of Schistosoma infections by measurement of circulating antigens in serum and urine. Trop. Geogr. Med. 46:1994;233-238.
10. Doehring E., Feldmeier H.and, Dafalla A.A. Day-to-day variation and circadian rhythm of egg excretion in urinary schistosomiasis in the Sudan. Ann. Trop. Med. Parasitol. 77:1983;587-594.
11. Doehring E., vester U., Ehrich J.H.H., Feldmeier H. Circadian variation of ova excretion, proteinuria, haematuria and leukocyturia in urinary schistosomiasis. Kidney Int. 27:1985;667-671.
12. Doehring E., Ehrich J.H.H., Reider F., Dittrich M., Schmidt-Ehry G., Brodehl J. Morbidity in urinary schistosomiasis: relation between sonographical lesions and pathological urine findings. Trop. Med. Parasitol. 36:1985;145-149.
13. Eltoum I.A., Ghalib H.W., Suliaman S., Kordofani A., Mustafa M.D., Homeida M. Significance of eosinophiluria in urinary schistosomiasis. A study using Hansel's stain and electron microscopy. Am. J. Clin. Pathol. 92:1989;329-388.
14. Eltoum I.A., Suliaman S., Ismail B.M., Ismail A.I.A., Ali M.M.M., Homeida M. Evaluation of eosinophiluria in the diagnosis of schistosomiasis haematobium: a field-based study. Am. J. Trop. Med. Hyg. 46:1992;732-736.
15. Feldmeier H., Doehring E., Dafalla A.A. Simultaneous use of a sensitive filtration technique and reagent strips in urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 76:1982;416-421.
16. Feldmeier H., Poggensee G., Krantz I., Helling-Giese G. Female genital schistosomiasis. New challenges from a gender perspective. Trop. Geogr. Med. 47(Suppl. 2):1995;2-15.
17. Fredens K., Dybdahl H., Dahl R., Baandrup U. Extracellular deposits of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage. APMIS. 96:1988;711-719.
18. Giboda M., Smith J.M. Schistosoma mansoni eggs as a target for Praziquantel: efficacy of oral application in mice. J. Trop. Med. Hyg. 97:1994;98-102.
19. Gryseels B. The relevance of schistosomiasis for public health. Trop. Med. Par. 40:1989;134-142.
20. Hammad T.A., Gabr N.S., Talaat M.M., Orieby A., Shawky E., Strickland G.T. Haematuria and proteinuria as predictors of Schistosoma haematobium infection. Am. J. Trop. Med. Hyg. 57:1997;363-367.
21. Hatz C., Savioli L., Mayombana C., Dhunputh J., Kisumku U.M., Tanner M. Measurement of schistosomiasis-related morbidity at community level in areas of different endemicity. Bull. WHO. 68:1990;777-787.
22. Hatz C., Jenkins J.M., Meudt R., Abdel-wahab M.F., Tanner M. A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 1. Schistosoma haematobium. Acta Trop. 51:1992;1-14.
23. Hatz C.F., Vennervald B.J., Nkulila T., Vounatsou P., Kombe Y., Mayombana C. Evolution of Schistosoma haematobium - related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am. J. Trop. Med. Hyg. 59:1998;775-781.
24. Kahama, A.I., 1998. Detection of circulating soluble egg antigen, SEA. in human urinary schistosomiasis. Ph.D. Thesis, Leiden University Medical Centre, The Netherlands.
25. Kahama A.I., Nibbeling H.A., van Zeyl R.J.M., Vennervald B.J., Ouma J.H., Deelder A.M. Detection and quantification of soluble egg antigen in urine of Schistosoma haematobium-infected children from Kenya. Am. J. Trop. Med. Hyg. 59:1998;769-774.
26. Kahama A.I., Kremsner P.G., van Dam G.J., Deelder A.M. The dynamics of a soluble egg antigen of Schistosoma haematobium in relation to egg counts, circulating anodic and cathodic antigens and pathology markers before and after chemotherapy. Trans. R. Soc. Trop. Med. Hyg. 92:1998;629-633.
27. Kahama A.I., Odek A.E., Kihara R.W., Vennervald B.J., Kombe Y., Nkulila T., Hatz C.F., Ouma J.H., Deelder A.M. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya. Am. J. Trop. Med. Hyg. 61:1999;215-219.
28. Kjetland E.F., Poggensee G., Helling-Giese G., Richter J., Sjaastad A., Chitsulo L., Kumwenda N., Gundersen S.G., Krantz I., Feldmeier H. Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi. Acta Trop. 62:1996;239-255.
29. Kleine T.J., Gleich G.J., Lewis S.A. Eosinophil major basic protein increases membrane permeability in mammalian urinary bladder epithelium. Am. J. Physiol. 275:1998;93-103.
30. Kremsner P.G., Enyong P., Krijger F.W., De Jonge N., Zotter G.M., Thalhammer F., Mühlschlegel F., Bienzle U., Feldmeier H., Deelder A.M. Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study. Clin. Infect. Dis. 18:1994;408-413.
31. Lengeler C., Komba S., Morona D. Urinary schistosomiasis: influence of the circadian variation of haematuria and proteinuria on reagent stick testing. Acta Trop. 48:1991;313-317.
32. Lengeler C., Mshinda H., Morona D., de Savigny D. Urinary schistosomiasis: testing with urine filtration and reagent stick for haematuria provides a comparable prevalence estimate. Acta Trop. 53:1993;39-50.
33. Leutscher P., Ravaoalimalala V.E., Raharisolo C., Ramarokoto C.E., Rasendramino M., Raobelison A. et al. Clinical findings in female genital schistosomiasis in Madagascar. Trop. Med. Int. Health. 3:1998;327-332.
34. Leutscher P.D., Ramarokoto C.-E., Reimert C.M., Feldmeier H., Esterre P., vennervald B.J. Community-based study of genital schistosomiasis in men from Madagascar. Lancet. 355:2000;117-118.
35. Leutscher P.D.C., Reimert C.M., Vennervald B.J., Ravaoalimalala V.E., Ramarakoto C.E., Serieye J., Raobelison A., Rasendramino M., Christensen N.O., Esterre P. Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine. Trop. Med. Int. Health. 5:2000;88-93.
36. Lwambo N.J.S., Savioli N., Kisumku U.M., Alawi K.S., Bundy D.A.P. The relationship between prevalence of Schistosoma haematobium infection and different morbidity indicators during the course of a control programme on Pemba Island. Trans. R. Soc. Trop. Med. Hyg. 91:1997;643-646.
37. Nibelling H.A.M., Kahama A.I., van Zeyl R.J.M., Deelder A.M. Use of monoclonal antibodies prepared against Schistosoma mansoni hatching fluid antigens for demonstration of Schistosoma haematobium circulating egg antigens. Am. J. Trop. Med. Hyg. 57:1998;337-341.
38. Nolan C.R., Keller S.P. Eosinophiluria. Clin. Lab. Med. 8:1988;555-565.
39. Owhwashi M., Horii Y., Ishii A. Eosinophil chemotactic factor in schistosome eggs: a comparative study of eosiniphil chemotactic factors in eggs of Schistosoma japonicum and S. mansoni in vitro. Am. J. Trop. Med. Hyg. 32:1983;359-366.
40. Poggensee G., Reimert C.M., Nilsson L.-Å., Jamaly S., Sjastad A., Roald B., Kjetland E.F., Helling-Giese G., Richter J., Chitsulo L., Kumwenda N., Gundersen S.G., Krantz I., Feldmeier H. Diagnosis of female genital schistosomiasis by indirect disease markers: determination of eosinophil cationic protein, neopterin and IgA in vaginal fluid and swab eluates. Acta Trop. 62:1996;269-280.
41. Poggensee G., Kiwelu I., Weger V., Göppner D., Diedrich T., Krantz I., Feldmeier H. Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in Northern Tanzania. J. Infect. Dis. 181:2000;1210-1213.
42. Reimert C.M., Venge P., Kharazmi A., Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J. Immunol. Methods. 138:1991;285-290.
43. Reimert C.M., Ouma J.H., Mwanje M.T., Magak P., Poulsen L.K., Vennervald B.J., Christensen N.Ø., Kharazmi A., Bendtzen K. et al. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX). Acta Trop. 54:1993;1-12.
44. Reimert C.M., Mshinda H.M., Hatz C.F., Kombe Y., Nkulila T., Poulsen L.K., Christensen N.Ø., Vennervald B.J. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity. Am. J. Trop. Med. 62:2000;19-28.
45. Savioli L., Hatz C., Dixon H., Kisumku U.M., Mott K.E. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and haematuria as indicators of infection. Am. J. Trop. Med. Hyg. 43:1990;289-295.
46. Simonsen P.E., Dunyo S.K. Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. Trans. R. Soc. Trop. Med. Hyg. 93:1999;278-282.
47. Smith J.H., Christie J.D. The pathobiology of Schistosoma haematobium in humans. Hum. Pathol. 17:1986;333-345.
48. Stephenson L.S., Latham M.C., Kinoti S.N., Oduori M.L. Sensitivity and specificity of reagent strips in screening of Kenyan children for Schistosoma haematobium infection. Am. J. Trop. Med. Hyg. 33:1984;862-871.
49. Tanner M. Evaluation and monitoring of schistosomiasis control. Trop. Med. Par. 40:1989;207-213.
50. Tanner M. From the bench to the field: infections within primary health care. Parasitology. 99:1989;81-92.
51. Van Etten L., Folman C.C., Eggelte T.A., Kremsner P.G., Deelder A.M. Rapid diagnosis of schistosomiasis by antigen detection in urine with a reagent strip. J. Clin. Microbiol. 32:1994;2404-2406.
52. Van Etten L., Van Lieshout L., Mansour M.M., Deelder A.M. A reagent strip antigen capture assay for the assessment of cure in schistosomiasis patients. Trans. R. Soc. Trop. Med. Hyg. 91:1997;154-155.
53. Vennervald B.J., Ouma J.H., Butterworth A.E. Morbidity in schistosomiasis: assessment, mechanisms and control. Parasitol. Today. 14:1998;385-390.
54. Wagatsuma Y., Aryeetey M.E., Sack D.A., Morrow R.H., Hatz C., Kojima S. resolution and resurgence of Schistosoma haematobium-induced pathology after community-based chemotherapy in Ghana as detected by ultrasound. J. Infect. Dis. 179:1999;1515-1522.
55. Warren K.S., Mahmoud A.A.F., Muruka J.F., Whittacker L.R., Ouma J.H., arap Siongok T.K. Schistosomiasis haematobium in coast province Kenya. Relationship between egg output and morbidity. Am. J. Trop. Med. Hyg. 28:1979;864-870.
56. Witkin S.S., Jeremias J., Ledger W.J. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J. Med. Vet. Mycol. 27:1989;57-58.
57. World Health Organization, 1985. The control of schistosomiasis. Report of a WHO Expert Committee. WHO Tech. Rep. Ser. 728, Geneva.
58. World Health Organization, 1991. Meeting on ultrasonography in schistosomiasis. Proposal for a practical guide to the standardized use of ultrasound in the assessment of pathological changes. TDR/SCH/ULTRASON/91.3, Geneva.